• This record comes from PubMed

Distribution of pathogenicity island markers in commensal and uropathogenic Escherichia coli isolates

. 2016 May ; 61 (3) : 261-8. [epub] 20151112

Language English Country United States Media print-electronic

Document type Journal Article

Links

PubMed 26563230
DOI 10.1007/s12223-015-0433-8
PII: 10.1007/s12223-015-0433-8
Knihovny.cz E-resources

Uropathogenic Escherichia coli (UPEC) isolates contain large genomic segments, termed pathogenicity islands (PAIs), that contribute to their virulence. A total of 150 UPEC and 50 commensal E. coli isolates from outpatients were investigated for antimicrobial susceptibility and the presence of eight PAI markers. One hundred ninety (95 %) isolates were resistant to one or more antimicrobial agents. The most frequent resistance found against amoxicillin (68 %), amoxicillin/clavulanic acid (55 %), aztreonam (50 %), trimethoprim/sulfamethoxazole (46 %) and tetracycline (43.5 %). Antimicrobial resistance among UPEC isolates was higher than that of commensals. PAI markers were detected in substantial percentage of commensal (88 %) and UPEC isolates (98.6 %) (P > 0.05). The most prevalent PAI marker among UPEC and commensal isolates was PAI IV536 (98.7 % UPEC vs. 84 % commensal). We found a high number of PAI markers such as PAI ICFT073, PAI IICFT073, PAI I536, PAI II536, PAI III536 and PAI IIJ96 significantly associated with UPEC. PAI III536 (21.3 %) and PAI IIJ96 (8 %) were detected only in the uropathogenic isolates. Several different combinations of PAIs were found among UPEC isolates. Comparison of PAIs among UPEC and commensal isolates showed that many UPEC isolates (79.3 %) carried two or more PAI markers, while 6 % of commensals had two PAI markers (P < 0.05). The most frequent combinations of PAI markers in UPEC isolates were PAI IV536 + PAI IICFT073 (18 %) and PAI IV536 + PAI ICFT073 + PAI IICFT073 (18 %). These results indicate that PAI markers are widespread among commensal and UPEC isolates and these commensal isolates may be reservoirs for transmission of these markers.

See more in PubMed

Cell Microbiol. 2006 Nov;8(11):1707-19 PubMed

Ann Lab Med. 2014 Mar;34(2):139-44 PubMed

Braz J Microbiol. 2011 Oct;42(4):1308-13 PubMed

Pathogens. 2014 Mar 31;3(2):238-48 PubMed

Braz J Med Biol Res. 2008 Oct;41(10):877-83 PubMed

BMC Bioinformatics. 2005 Jul 21;6:184 PubMed

Curr Opin Microbiol. 2009 Oct;12(5):476-81 PubMed

Nat Rev Microbiol. 2010 Aug;8(8):552-63 PubMed

Appl Environ Microbiol. 2010 Oct;76(19):6698-700 PubMed

Ann Clin Microbiol Antimicrob. 2009 Dec 08;8:34 PubMed

Infect Immun. 2002 Nov;70(11):6365-72 PubMed

Pathogens. 2014 Jan 13;3(1):36-56 PubMed

Appl Environ Microbiol. 2013 Jun;79(11):3406-12 PubMed

Med Sci Monit. 2013 May 01;19:317-26 PubMed

Clin Microbiol Rev. 2004 Jan;17(1):14-56 PubMed

Jundishapur J Microbiol. 2015 Feb 07;8(2):e17514 PubMed

Biomed Res Int. 2014;2014:465054 PubMed

Arch Iran Med. 2012 May;15(5):312-6 PubMed

Clin Microbiol Infect. 2006 Sep;12(9):880-6 PubMed

Appl Environ Microbiol. 2011 Apr;77(7):2303-8 PubMed

FEMS Microbiol Lett. 2006 Jan;254(1):75-80 PubMed

J Bacteriol. 2004 May;186(10):3086-96 PubMed

Microb Pathog. 1990 Mar;8(3):213-25 PubMed

Genet Mol Res. 2011 Oct 31;10(4):4114-25 PubMed

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...